Biology Reference
In-Depth Information
[85] Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, et al. Bone
marrow transplantation for severe aplastic anemia: a randomized controlled study of
conditioning regimens. Blood 2007;109:4582-5.
[86] Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA, et al. Optimization of con-
ditioning for marrow transplantation from unrelated donors for patients with aplastic
anemia after failure of immunosuppressive therapy. Blood 2006;108:1485-91.
[87] Yu C, Seidel K, Nash RA, Deeg HJ, Sandmaier BM, Barsoukov A, et al. Synergism be-
tween mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease
among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood
1998;91:2581-7.
[88] Maris MB, Niederwieser D, Sandmaier BM, Storer B, Stuart M, Maloney D, et al. HLA-
matched unrelated donor hematopoietic cell transplantation after nonmyeloablative
conditioning for patients with hematologic malignancies. Blood 2003;102:2021-30.
[89] Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, et al. Protec-
tive conditioning for acute graft-versus-host disease. N Engl J Med 2005;353:1321-31.
[90] Storb R, Deeg HJ. Failure of allogeneic canine marrow grafts after total-body irradia-
tion. Allogeneic “resistance” versus transfusion-induced sensitization. Transplantation
1986;42:571-80.
[91] Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Flournoy N, Martin PJ, et al. Marrow
transplantation from related donors other than HLA-identical siblings. N Engl J Med
1985;313:765-71.
[92] Lapidot T, Terenzi A, Singer TS, Salomon O, Reisner Y. Enhancement by dimethyl my-
leran of donor type chimerism in murine recipients of bone marrow allografts. Blood
1989;73:2025-32.
[93] Bachar-Lustig E, Rachamim N, Li HW, Lan F, Reisner Y. Megadose of T cell-depleted
bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med
1995;1:1268-73.
[94] Goodman JW, Burch KT, Basford NL. Graft-vs.-Host activity of thymocytes: relationship
to the role of thymocytes in hemopoiesis. Blood 1972;39:850-61.
[95] Storb R, Epstein RB, Bryant J, Ragde H, Thomas ED. Marrow grafts by combined mar-
row and leukocyte infusions in unrelated dogs selected by histocompatibility typing.
Transplantation 1968;6:587-93.
[96] Deeg HJ, Storb R, Weiden PL, Shulman HM, Graham TC, Torok-Storb BJ, et al. Abroga-
tion of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in
lethally irradiated dogs by thoracic duct lymphocytes. Blood 1979;53:552-7.
[97] Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, et al. Marrow
transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia
patients. Blood 1982;59:236-46.
[98] Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, et al. Successful en-
graftment of T-cell-depleted haploidentical “three-loci” incompatible transplants in
leukemia patients by addition of recombinant human granulocyte colony-stimulating
factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood
1994;84:3948-55.
[99] Aversa F. Setting the standard in T-cell-depleted haploidentical transplantation and
beyond. Best Pract Res Clin Haematol 2011;24:325-9.
[100] Sideri A, Neokleous N, De La Grange PB, Guerton B, Le Bousse Kerdilles MC, Uzan G,
et al. An overview of the progress on double umbilical cord blood transplantation.
Haematologica 2011;96:1213-20.
[101] Delaney C, Ratajczak MZ, Laughlin MJ. Strategies to enhance umbilical cord blood
stem cell engraftment in adult patients. Expert Rev Hematol 2010;3:273-83.
[102] Shizuru JA, Jerabek L, Edwards CT, Weissman IL. Transplantation of purified hemato-
poietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
Biol Blood Marrow Transplant 1996;2:3-14.
[103] Bachar-Lustig E, Li HW, Gur H, Krauthgamer R, Marcus H, Reisner Y. Induction of
donor-type chimerism and transplantation tolerance across major histocompatibil-
ity barriers in sublethally irradiated mice by Sca-1(+)Lin(−) bone marrow progenitor
cells: synergism with non-alloreactive (host × donor)F(1) T cells. Blood 1999;94:
3212-21.
[104] Rachamim N, Gan J, Segall H, Krauthgamer R, Marcus H, Berrebi A, et al. Tolerance in-
duction by “megadose” hematopoietic transplants: donor-type human CD34 stem cells
induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors
in mixed lymphocyte culture. Transplantation 1998;65:1386-93.
[105] Gur H, Krauthgamer R, Berrebi A, Klein T, Nagler A, Tabilio A, et al. Tolerance induction
by megadose hematopoietic progenitor cells: expansion of veto cells by short-term
culture of purified human CD34(+) cells. Blood 2002;99:4174-81.
119
Search WWH ::
Custom Search